Patient survey (HCAHPS) - State
A list of the state averages for the HCAHPS survey responses. HCAHPS is a national, standardized survey of hospital patients about their experiences during a recent inpatient hospital stay.
$0
estimated
The Federal Trade Commission will prohibit data broker Kochava and its subsidiary from selling, sharing or disclosing sensitive location data without consumers’ affirmative express consent to settle allegations the companies sold location data from hundreds of millions of mobile devices that could be used to trace the movements of individuals. The FTC sued Idaho-based Kochava in August 2022 alleging that its collection, use and disclosure of precise location data invaded consumers’ privacy by revealing their movements, including visits to sensitive locations such as health facilities and places of worship. The FTC alleged that because consumers were unaware of and did not consent to this data sharing, consumers had no way of avoiding the harm resulting from its collection and disclosure. Under the proposed order resolving the FTC’s litigation, Kochava and its subsidiary, Collective Data Solutions (CDS), which has taken over Kochava’s data broker business, will be prohibited from selling, licensing, transferring, sharing or disclosing sensitive location data in any products or services unless they obtain a consumer’s affirmative express consent and the data is used to provide a service directly requested by the consumer. The subsidiary and Kochava (if Kochava sells or uses precise location data) also are required to: Establish and implement a sensitive location data program to develop a comprehensive list of sensitive locations to prevent the sale, transfer or disclosure of sensitive location data; Implement a supplier assessment program designed to confirm that consumers have provided consent for the collection and use of all location data obtained by the subsidiary or Kochava; Submit incident reports to the FTC when the companies determine a third party shared consumers’ precise location data in violation of contractual requirements; Allow consumers to request the names of any business or individual to which CDS or Kochava has knowledge that consumers’ precise location data was sold, and provide consumers with an easy way to withdraw consent for the sale of their device’s precise location data; and Create a data retention schedule that will require the deletion of data on an established timeframe. The Commission vote approving the stipulated final order was 2-0. The FTC filed the proposed order in the U.S. District Court for the District of Idaho. NOTE: Stipulated final orders have the force of law when approved and signed by the District Court judge. The lead attorneys on this matter are Jennifer Rimm, Erik Jones, Mike Sherling, Elizabeth C. Scott, and Julia Horwitz in the FTC’s Bureau of Consumer Protection.
Pay it forward
The average person is owed $300+they don't know about. Sharing takes 10 seconds and could put real money in a friend's pocket.
A list of the state averages for the HCAHPS survey responses. HCAHPS is a national, standardized survey of hospital patients about their experiences during a recent inpatient hospital stay.
$0
estimated
The Healthcare-Associated Infections (HAI) measures - national data. These measures are developed by Centers for Disease Control and Prevention (CDC) and collected through the National Healthcare Safety Network (NHSN). They provide information on infections that occur while the patient is in the hospital. These infections can be related to devices, such as central lines and urinary catheters, or spread from patient to patient after contact with an infected person or surface. Many healthcare associated infections can be prevented when the hospitals use CDC-recommended infection control steps.
$0
estimated
Value-Based Incentive Payment Amount displays the number of hospitals that received value-based incentive payment amounts in ranges of $50,000.
$0
estimated
Unplanned Hospital Visits: state data. This data set includes state-level data for the hospital return days (or excess days in acute care [EDAC]) measures, the unplanned readmissions measures, and measures of unplanned hospital visits after outpatient procedures.
$0
estimated